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Abstract
Introduction: Melanoma is the most worrisome melanocytic skin lesion. It is also one of the most malignant tumours,
and rapidly forms metastases. Melanoma incidence and mortality rates are increasing in most countries through-
out the world.
Aim: To analyse retrospectively the history of patients who were diagnosed with malignant melanoma at the Depart-
ment of Dermatology Jagiellonian University, Krakow. 
Material and methods: Using retrospective data we analysed history cases of 194 patients, 83 men (42.8%) and 111
women (57.2%) with melanoma. The patients’ age, sex, location and number of the lesions and melanoma type
were analysed. Statistical analysis was performed using STATISTICA. 
Results: According to the observations there was a significant increase of morbidity rate between 1991 (1 case) and
2001 (23 cases). In all investigated populations melanoma was more commonly observed on the trunk (37.5%) than
on the head and neck (2.1%). Melanomas were predominant on the trunk in males (51.2%), and equally on the low-
er limb and trunk for females (27.3%, p = 0.003). In most cases melanoma developed from a pre-existing naevus
(64.4%). Lentigo maligna was found on sun-exposed areas in 72.2% of cases, mostly among patients over 60 years
old. Nodular melanoma was the predominant type (30.7%), while acral lentiginous melanoma was the rarest one
(1%). Most of the melanoma cases were at Clark level IV when diagnosed (32.8%), whereas cases at Clark level V
were found in 5.2%. The majority of melanoma lesions were at Breslow stage III and IV when excised (p = 0.006).
Conclusions: Our results confirmed that patients with melanoma had decided to visit the dermatologist too late,
when the tumour was at an advanced stage. There is still insufficient knowledge of the self-examination of the nae-
vi as well as of the need for regular dermatological examination of suspicious lesions and early surgical excision if
necessary. 
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Introduction
Melanoma is the most worrisome melanocytic skin
lesion. It is also one of the most malignant tumours, and
rapidly forms metastases. Melanoma incidence and
mortality rates are increasing not only in Poland [1] but
also in most countries throughout the world [2-5]. The
most common melanoma location is skin, but it could
develop as well in the mucosa, eyes and other internal
organs [6]. In 70% of cases melanoma develops de novo
(on previously unchanged skin), but also it could arise
from pre-existing melanocytic lesions, such as congenital
melanocytic naevi, dysplastic naevi (both single and
dysplastic naevi syndrome), common naevi (marginal type
with dermo-epidermal component) and blue naevi [7].
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Melanoma has many clinical presentations: from small,
flat macules up to notably nodular lesions. Clinical and
histological features determining the disease prognosis
include the Breslow index, tumour size, presence of
ulceration and mitotic rate [8]. The Breslow index is based
on histological measurement of the tumour tissue
thickness and it is still one of the most important
prognostic factors [9]. Surgical excision of the lesion with
Breslow thickness < 0.75 mm gives 95% 5-year survival
and 92% 10-year survival, whereas the prognosis is
reduced to 46% 5-year-survival and 38% 10-year survival
when it is > 4 mm [10]. Early melanoma diagnosis and
surgical excision of a suspicious lesion have a significant
role in disease treatment [7, 11, 12].
Aim
The aim of the study was to analyse retrospectively
the history of patients treated for malignant melanoma
in the Department of Dermatology, Jagiellonian University,
Krakow. 
Material and methods
The statistical analysis included case histories of 194
patients, 83 men (42.3%) and 111 women (57.2%). The
patients’ age, sex, location and number of the lesions and
type of melanoma were analysed. The median age was
similar among male and female patients, and was 60
years for men and 59 years for women. Morbidity rate
was examined separately in each year, as well as
melanoma incidence in a particular location, its
histological type, and advancement stage (according to
the Clark and Breslow scale). The incidence of melanoma
arising from unchanged skin (de novo) and from pre-
existing melanocytic lesions were also compared. The data
analyses were performed with descriptive statistical
analysis (χ2 test, Student’s t-test) and cross tables with 
p < 0.05 as the condition for statistical significance.
Statistical analysis was performed using STATISTICA.
Results
There was a significant increase in melanoma
incidence between 1991 and 2001 (Fig. 1). In the whole
investigated group (male and female) in 72 cases (37.5%)
melanoma developed on the trunk, in 39 cases on lower
limbs (20.3%), in 37 cases on upper limbs (19.3%) and in
4 cases (2.1%) on the head and neck (Tab. 1). There were
no data regarding lesions’ location in 2 melanoma cases.
Analysis of our data showed statistical significance 
(p = 0.002). 
A statistically significant correlation was noted
between sex and melanoma location (p = 0.003, Tab. 2).
Among male patients melanoma was more frequent on
the trunk (42 cases – 51.2%), while among female patients
the lower limbs and trunk were equally often affected
(each location 30 cases – 27.3%). Melanoma in upper limb
location was more common in women (26 case) than men
(11 cases), but the difference was not statistically
significant.
64.4% of melanoma developed in pre-existing naevi
(125 patients). In 27.3% of cases melanoma arose de novo
(53 patients, Fig. 2).
Lentigo maligna was mostly found among patients
over 60 years old (66.7%) on sun-exposed areas –
forearms, face, head, shoulders (72.2%, Tab. 3-4). But the
results were not statistically significant (p = 0.120).
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Tab. 1. Melanoma location
Location Number of cases Percent
Trunk 72 37.5
Lower limbs 39 20.3
Upper limbs 37 19.3
Face 33 17.2
Palms and feet 7 3.6
Head and neck 4 2.1
Tab. 2. The relationship between sex and melanoma loca-
tion
Location Men Women
n % n %
Face 15 18.3 18 16.4
Head and neck 3 3.7 1 0.9
Trunk 42 51.2 30 27.3
Lower limbs 9 11.0 30 27.3
Upper limbs 11 13.4 26 23.6
Palms and feet 2 2.4 5 4.5
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Fig. 1. Melanoma incidence rate in the population of the
region of Małopolska and Podkarpacie
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Fig. 3. Melanoma type
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Fig. 4. Melanoma – Clark level (scale)
Fig. 2. Melanoma – the background of the lesions
De novo
In a pre-existing nevi
No data
64.40%
27.30%
30.7
34.9
19
36
53
63
10 11
13.5
9.4 9.4
1.0 1.0
8.30%
Tab. 3. The relationship between the prevalence of lentigo
maligna and exposure to UV
Frequency Percent
Non-exposed 5 27.8
Exposed 13 72.2
Total 18 100
Tab. 4. The relationship between the prevalence of lentigo
maligna and age
Age [years] Frequency Percent
41-60 6 33.3
> 60 12 66.7
Total 18 100
Fig. 5. Melanoma – location and Clark level
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Nodular melanomas were found in 30.7% of cases (the
most common type), acral lentiginous melanoma (AML)
in 1% of cases. However, in most cases (34.9%)
histological type was unspecified (Fig. 3).
Among histological parameters there were 9.9% of
lesions at Clark level I, 18.8% at level II, 27.6% at level III,
32.8% at level IV and 5.2% at level V. In 11 cases Clark level
was unspecified (Fig. 4). Analysis of our data did not show
statistical significance (p = 0.120).
We also analysed the relationship between melanoma
location and Clark level (Fig. 5). In all locations comparable
numbers of lesions at Clark level III and IV were found.
Acral lesions were the only exception, with 71.4% of cases
at Clark level IV.
According to Breslow thickness significantly greater
numbers of nodular melanoma were at stage III and IV 
(p = 0.006; Tab. 5).
Discussion
We noticed that there was a great increase in
melanoma cases between 1991 and 2001. This
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observation is in agreement with the worldwide tendency
which was observed by other authors [1-5]. This
phenomenon may be due to increased sun exposure.
Furthermore, frequent exposure to short-term UV
radiation (e.g. during holidays) is a proven melanoma risk
factor [13-15]. On the other hand, improved patient
knowledge about melanoma and proper skin examination
of suspicious lesions may cause better diagnosis of
melanoma. The most common melanoma location among
male patients was the trunk (51.2%); the same
observation was presented in recent literature [16, 17].
Among female patients melanoma was located on the
trunk as often as on lower limbs (by 27.3%). Data reported
by other authors with respect to melanoma location
among female patients is discrepant: some authors
indicated its greater incidence on the lower limbs than in
other areas of the body. Newnham and Moller [16] noticed
that, regardless of the vast number of melanoma cases
located on the lower limbs, the frequency of melanoma
on the trunk significantly increased. Our results suggest
that the high number of melanomas in the analysed
period was caused mostly by melanoma located on the
trunk. Clark et al. [18] found that in 2004 melanomas
among women were more often located on the trunk
compared with years 1972-1977. Also, Garbe et al. [19]
confirmed that among women from Central European
countries melanoma occurred more frequently on the
trunk. The most probable reason for this phenomenon is
specific cultural behaviour such as “dress code” and sun
exposure habits in that population. In all the investigated
group melanoma developed more often from pre-existing
melanocytic naevi (64.4%) than de novo. Other authors,
however, did not confirm such a correlation. Most of them
postulated that melanoma develops from pre-existing
melanocytic naevi in 12% up to 36% of cases [20-25]. The
results of Skender-Kalnenas et al. [26] are the most similar
to ours: melanoma developed from melanocytic naevi in
51% of cases. Most of the patients whose data we
analysed were directed to our surgery department from
the dermoscopy department of the same clinic. It is
tempting to suggest that 64.4% of our melanoma cases
developed from pre-existing melanocytic naevi because
of the correlation between melanoma type, UV exposure
and patients’ age. In our data lentigo maligna mostly
affected elderly patients in sun-exposed areas (forearms,
face, head and shoulders), which is in agreement with
other authors [27-29]. Therefore there is a great necessity
in UV protection, especially for elderly people. Delays in
dermoscopy examination are mainly caused by
insufficient knowledge about the early melanoma
symptoms, as well as misconceptions about the
inevitability of death. The risk of developing melanoma
increases with age, especially in men. The worst
prognostic factors are tumour thickness > 3 mm according
to Breslow and nodular clinical type, which are common
in elderly people [30]. Nagore et al. showed that there is
a great need for special attention to the group of male
patients over 60 years of age, because in these
patients MM is detected in the advanced stage [31]. In our
study the most frequent was nodular melanoma – 30.7%
of lesions with a defined histological type; 13.5% were
lentigo maligna melanoma (LMM); and 9.4% were lentigo
maligna (LM) and superficial spreading melanoma (SSM).
The rarest was acral lentiginous melanoma (ALM) at 1%.
According to other data NM ranges from a dozen [17, 32]
to about 30% of cases of melanoma [29, 33]. At this point
our results are similar to other studies. It is interesting
that there were only a few SSM in our data. This
histological type is considered to be the most common
one, reaching 70% of melanomas [9, 34]. Acral lentiginous
melanoma in our study occurred as frequently as in other
authors’ observations [6, 7, 35, 36]. Clark IV (32.8%) and
Clark III (27.6%) were the most frequent levels. The results
presented by other authors are similar, with a slight
predominance of Clark level III [19, 37].
There were 64.6% of cases with tumour thickness 
> 1.5 mm and among them 29.2% had lesions thicker than
4 mm. Other authors, however, reported quite the
opposite data: most melanoma lesions were < 1.5 mm
according to the Breslow scale [17, 19, 38].
Our results confirm that patients are often diagnosed
at the advanced stage. Furthermore, our study proved
a correlation with a significant number of nodular
melanomas, especially with respect to the Breslow scale.
NM is the most invasive type of melanoma. Almost from
the beginning it has a vertical growth. NM is usually
diagnosed very late. It often does not meet the criteria of
the commonly used clinical classification ABCD [38, 39],
which makes fast and correct diagnosis difficult.
Conclusions
• The most common melanoma location for both sexes
was the trunk.
• Lentigo maligna was more often diagnosed among old
patients on sun-exposed areas (forearms, face, head,
shoulders); therefore patients over 60 years old have to
protect their skin from sun burning and pay more
attention to self-examination for the early detection of
dangerous lesions.
• Among our patients nodular melanoma was the most
common one, which is why the prognosis was worse
from the beginning.
Tab. 5. Melanoma – histological type and Breslow thickness
Histopatotogical Thickness [mm]
type
≤ 0.75 0.76-1.5 1.51-3.99 ≥ 4
ALM 0 0 1 1
LMM 2 1 1 0
MM 6 6 5 4
NM 0 3 14 14
SSM 5 0 2 0
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• Most of the lesions were diagnosed at Clark IV and 
Clark III, Breslow IV level. Melanoma is highly treatable
in its earlier stages; hence there is a great necessity of
public education of the early signs of melanoma, which
could improve the accuracy of skin self-examination,
and would allow the targeted interventions of
dermatologists to be successful.
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